114 related articles for article (PubMed ID: 6681773)
1. Differing electrical surface charge and transplantation properties of genetically variant sublines of the TA3 murine adenocarcinoma tumor.
Tenforde TS; Adesida PO; Kelly LS; Todd PW
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):277-82. PubMed ID: 6681773
[TBL] [Abstract][Full Text] [Related]
2. Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growth.
Cooper AG; Codington JF; Miller DK; Brown MC
J Natl Cancer Inst; 1979 Jul; 63(1):163-9. PubMed ID: 221714
[TBL] [Abstract][Full Text] [Related]
3. Isolation and partial characterization of an epiglycanin-like glycoprotein from a new non-strain-specific subline of TA3 murine mammary adenocarcinoma.
Codington JF; Cooper AG; Miller DK; Slayter HS; Brown MC; Silber C; Jeanloz RW
J Natl Cancer Inst; 1979 Jul; 63(1):153-61. PubMed ID: 286825
[TBL] [Abstract][Full Text] [Related]
4. Concanavalin A and other lectins in the study of tumor cell surface organization.
Friberg S; Hammarström S
Adv Exp Med Biol; 1975; 55():245-60. PubMed ID: 1098413
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural and histochemical differences in cell surface properties of strain-specific and nonstrain-specific TA3 adenocarcinoma cells.
Miller SC; Hay ED; Codington JF
J Cell Biol; 1977 Mar; 72(3):511-29. PubMed ID: 838766
[TBL] [Abstract][Full Text] [Related]
6. Comparison of an immunoresistant and an immunosusceptible ascites subline from murine tumor TA3. I. Transplantability, morphology, and some physicochemical characteristics.
Friberg S
J Natl Cancer Inst; 1972 May; 48(5):1463-76. PubMed ID: 5030958
[No Abstract] [Full Text] [Related]
7. Two kinds of antigen suppression in tumor cells revealed by cell fusion.
Klein G; Friberg S; Harris H
J Exp Med; 1972 Apr; 135(4):839-49. PubMed ID: 5018053
[TBL] [Abstract][Full Text] [Related]
8. Cell surface characteristics of an allotransplantable TA3 ascites subline resulting from a process of immunoselection.
Codington JF; Das HR; Dalianis T; Klein G; Miller SC; Silber C; Lampert LA; Darby DM; Jeanloz RW
Cancer Res; 1983 Sep; 43(9):4373-81. PubMed ID: 6871870
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical and morphological characterization of a new allotransplantable mammary carcinoma ascites subline, TA3-St/ticol/-A.
Codington JF; Dalianis T; Miller SC; Das HR; Klein G; Lampert LA; Silber C; Darby DM; Jeanloz RW
Cancer Res; 1983 Sep; 43(9):4364-72. PubMed ID: 6871869
[TBL] [Abstract][Full Text] [Related]
10. Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell.
Miller SC; Codington JF; Klein G
J Natl Cancer Inst; 1982 Jun; 68(6):981-8. PubMed ID: 6953278
[TBL] [Abstract][Full Text] [Related]
11. Comparative lectin-binding and agglutination properties of the strain-specific, TA-3-St, and the non-strain-specific, TA3-Ha, murine mammary carcinoma ascites sublines. Further studies of receptors in epiglycanin.
Matsumoto I; Codington JF; Jahnke MR; Jeanloz RW; Osawa T
Carbohydr Res; 1980 Apr; 80(1):179-89. PubMed ID: 7363275
[TBL] [Abstract][Full Text] [Related]
12. Transplantability and antigenicity of two sublines of the TA3 tumor.
Sanford BH; Codington JF; Jeanloz RW; Palmer PD
J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
[No Abstract] [Full Text] [Related]
13. Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: studies on segregating TA3-HA hybrids.
Codington JF; Klein G; Cooper AG; Lee N; Brown MC; Jeanloz RW
J Natl Cancer Inst; 1978 Apr; 60(4):811-8. PubMed ID: 633390
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunodetection of murine mammary adenocarcinoma (TA3/Ha) lung and liver metastases with radioiodinated PNA.
Shysh A; Eu SM; Noujaim AA; Suresh MR; Longenecker BM
Int J Cancer; 1985 Jan; 35(1):113-9. PubMed ID: 3967949
[TBL] [Abstract][Full Text] [Related]
15. Comparative study on drug sensitivity of the TA3/Ha and TA3/St tumor sublines.
Gál F; Sugár J; Susan SR
Oncology; 1979; 36(2):84-8. PubMed ID: 460789
[TBL] [Abstract][Full Text] [Related]
16. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
[TBL] [Abstract][Full Text] [Related]
17. Site dependency of TA3 Ha allotransplantability.
Hagmar B; Ryd W
Transplantation; 1977 Jan; 23(1):93-7. PubMed ID: 835167
[TBL] [Abstract][Full Text] [Related]
18. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).
Fung PY; Longenecker BM
Cancer Res; 1991 Feb; 51(4):1170-6. PubMed ID: 1825477
[TBL] [Abstract][Full Text] [Related]
19. Discussion paper: dual effects of tumor antigens: induction of tumor resistance or tumor growth enhancement.
Nowotny A; Butler RC; Grohsman J; Keebler C
Ann N Y Acad Sci; 1976; 276():106-23. PubMed ID: 194513
[TBL] [Abstract][Full Text] [Related]
20. In vivo release of glycoprotein I from the Ha subline of TA3 murine tumor into ascites fluid and serum.
Cooper AG; Codington JF; Brown MC
Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1224-8. PubMed ID: 4524634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
